NEW DELHI, February 21, 2017 /PRNewswire/ --
10 in 1000 Live Births Suffer From Genetic Disorders
Genesrun in the family. No parent in this world would like to see their child affected by disorders which are severe and not curable.
Usually parents do not pay much attention to genetic disorders. This lack of awareness and ignorance has caused many
Igenomix has developed an advanced Carrier Genetic Test (CGT) that identifies if the patient is a carrier or not; thereby highlighting the risk they have for having children affected with that disease. If identified in advance, steps can be taken to ensure a healthy pregnancy. CGT is an important genetic test for family planning which determines the risk of having a child with genetic disorder. The test needs to be conducted on the parents. If the parents are identified as high risk for a particular disease, then they have options such as Preimplantation Genetic Diagnosis (PGD) or Gamete donation which can help in conceiving a healthy child. "Out of all cases analysed by Igenomix, 90% of the people were carriers of at least one genetic mutation," says Dr. Rajni Khajuria from Igenomix.
For example, if both partners are carriers of Thalassemia and Thalassemia minor themselves, they can conceive a healthy baby through assisted reproductive technologies with the help of Igenomix's Preimplantation Genetic Diagnosis (PGD) test.
PGD screens the embryos for genetic mutation which both parents are a carrier for and enables them to select those embryos which are not affected by genetic disorder. It is indicated for couples with known personal or family history of monogenic disorders such as cystic fibrosis, fragile X syndrome, spinal muscular dystrophies (SMA), Duchenne muscular dystrophy (DMD), Huntington disease, Beta Thalassemia and many more. Even Fertile couples who have a known history of a genetic condition in their families can consider PGD testing.
Igenomix is a bio-technology company providing advanced services in reproductive genetics. Its consolidated experience and advanced research capabilities make it one of the world leaders in this field and guarantee the provision of effective solutions tailored to different infertility problems. It is present in Valencia (Spain), Miami, Los Angeles, New York, Mexico City, Sao Paulo, Dubai and Delhi, with a workforce of over 170 professionals.
For further information about the company, please visit http://www.igenomix.co.in or follow them on Facebook.
Media Contact: Divya Bhasin firstname.lastname@example.org +91-(011)-6651-7800 Igenomix Marketing Dept. Igenomix
Subscribe to our Free Newsletters!